Cargando…
Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights
Neurological disorders like Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), epilepsy, traumatic brain injury (TBI), depression, and anxiety are responsible for thousands of deaths worldwide every year. With the increase in l...
Autores principales: | Kulkarni, Namrata Pramod, Vaidya, Bhupesh, Narula, Acharan S., Sharma, Shyam Sunder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762179/ https://www.ncbi.nlm.nih.gov/pubmed/34102977 http://dx.doi.org/10.2174/1570159X19666210608165509 |
Ejemplares similares
-
Caffeic Acid Phenethyl Ester (CAPE): Biosynthesis, Derivatives and Formulations with Neuroprotective Activities
por: Pérez, Rebeca, et al.
Publicado: (2023) -
In vitro and in vivo neuroprotective effect of caffeic acid phenethyl ester
por: Akyol, Sumeyya, et al.
Publicado: (2015) -
15-Multifaceted impact of caffeic acid phenethyl ester (CAPE) in experimental myocardial injuries
por: Akyol, Sümeyya, et al.
Publicado: (2015) -
Protective Effect of Caffeic Acid Phenethyl Ester (CAPE) on Amiodarone-Induced Pulmonary Fibrosisin Rat
por: Zaeemzadeh, Narjes, et al.
Publicado: (2011) -
Caffeic Acid Phenethyl Ester (CAPE) Prevents Development of STZ-ICV Induced dementia in Rats
por: Kumar, Manish, et al.
Publicado: (2017)